Compound Evidence File
#EC-2026-0931
4-Anilinopiperidine CAS 99918-43-1
Filed under Raw Materials. The bureau holds 54 laboratory returns for this compound from 26 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
26 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 9.2 | 8.5 | 9.8 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 9.2 | 8.8 | 9.5 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.4 | 7.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.4 | 7.2 | 9.3 | 24 May 2026 | 24 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 8.4 | 8.4 | 8.4 | 28 Mar 2025 | 28 Mar 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 | 8 Jul 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 7.6 | 7.4 | 7.7 | 9 Jun 2025 | 21 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 | 21 May 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 7.3 | 6.0 | 8.6 | 13 Jun 2025 | 19 Jan 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 7.3 | 7.3 | 7.3 | 13 Jun 2025 | 13 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 7.2 | 7.2 | 7.3 | 24 May 2026 | 24 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 7.2 | 5.8 | 8.6 | 8 Jul 2025 | 17 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 | 8 Jul 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 6.9 | 5.8 | 8.1 | 6 May 2025 | 24 May 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 | 13 Jun 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 6.7 | 6.0 | 7.5 | 13 Jun 2025 | 20 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 6 | 6.5 | 3.6 | 7.9 | 2 Apr 2025 | 25 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 2 | 6.3 | 5.0 | 7.7 | 11 Jun 2025 | 23 May 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 | 6 May 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 | 13 Feb 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 5.2 | 5.2 | 5.2 | 20 Jun 2025 | 20 Jun 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Feb 2025 | 13 Feb 2025 |
| PepLab SolutionsCASE #VI-2026-0431 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for 4-Anilinopiperidine CAS 99918-43-1 alone.